Advertisement

Diagnoses of the Sphingolipidoses with Labelled Natural Substrates

  • Lars Svennerholm
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 101)

Abstract

The number of sphingolipid storage diseases is the object of some disagreement. In Table I, eigh t diseases are delineated. Some researchers classify Sandhoff disease as a separate entity but we consider it a variant form of GM2-gangliosidosis. In our opinion it would be more appropriate to include the fucosidosis in which there is a storage of several neutral fucolipids and probably also of fucose-containing gangliosides (3, 4). The last disease is, in general, included among the oligosaccharidoses in most classification schemes and it is a good example of the difficulty in classifying diseases in which there is a genetic lesion of a lysosomal enzyme. These enzymes have a low degree of specificity and they are generally not specific for a given substance, but act on a certain type of linkage e.g. on a ß-galactosidic linkage in the GM1-gangliosidosis. This linkage can then be localized in a lipid, an oligosaccharide, a glycoprotein or a glycosaminoglycan.

Keywords

Fabry Disease Gauche Disease Synthetic Substrate Sodium Taurocholate Amniotic Fluid Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    BRADY, R.O.–The abnormal biochemistry of inherited disorders of lipid metabolism. Fed.Proc., 32: 1660–1667, 1973.PubMedGoogle Scholar
  2. 2.
    BOWEN, D.M. & RADIN, N.S.–Cerebroside galactosidase: A method for determination and a comparison with other lysosomal enzymes in developing rat brain. J.Neurochem., 16: 501–511, 1969.PubMedCrossRefGoogle Scholar
  3. 3.
    DAWSON, G. & TSAY, G.C. - Fucosidosis. In Current Trends in Sphingolipidoses and Allied Disorders,B.W.Volk & L.Schneck (eds.), Advances in Experimental Medicine and Biology, vol. 68, Plenum Press., New York, 1976, pp. 187–203Google Scholar
  4. 4.
    DURAND, P., BORRONE, C. & DELLACELLA, G.–Fucosidosis. J.Pediat., 75: 665–674, 1969.PubMedCrossRefGoogle Scholar
  5. 5.
    FREDRICKSON, D.S. & SLOAN, H.R.–Glucosyl ceramide lipidosis: Gaucher-s Disease. In The Metabolic Basis of Inherited Disease, J.B.Stanbury, J.B.Wyngaarden & D.S.Fredrickson (eds.), Mc GrawHill Book Co., New York, 1972, pp. 730–759.Google Scholar
  6. 6.
    GALJAARD, H., HOOGEVEEN, A., KEYZER, W., de WIT-VERBEEK, H.A., REUSER, A.J.J., HO, M.W. & ROBINSON, D.–Genetic heterogeneity in different variants of GM1-gangliosidosis studied by ß-galactosidase assays in (single) somatic hybrid cells. Nature (Lond), 257: 60–62, 1975.CrossRefGoogle Scholar
  7. 7.
    HARRIS, H.–The Principles of Human Biochemical Genetics, North-Holland Publishing Co., Amsterdam, 1970, pp. 121–134.Google Scholar
  8. 8.
    HARTREE, E.F.–Determination of protein. A modification of the Lowry method that gives a linear photometric response. Anal.Biochem., 48: 122–127, 1972.CrossRefGoogle Scholar
  9. 9.
    HIRSCHHORN, K., BERATIS, N.G. & TURNER, B.M.–a-L-Fucosidase in normal and deficient individuals. In Current Trends in Sphingolipidoses and Allied Disorders, B.W.Volk & L.Schneck (eds.), Plenum Press, New York, 1976, pp. 205–223.CrossRefGoogle Scholar
  10. 10.
    HO, M.W.–Identity of “acid” ß-glucosidase and glucocerebrosidase in human spleen. Biochem.J., 136: 721–729, 1973.PubMedGoogle Scholar
  11. 11.
    JOHANNSEN, W. - Elemente der exakten Erblich Keiblehre, 1909, G.Fischer, Jena.Google Scholar
  12. 12.
    KABACK, M.M. & 0-BRIEN, J.S.–Tay-Sachs: Prototype for prevention of genetic disease. In Medical Genetics, V.A. Mc Kusick & R. Claiborne (eds.), H.P.Publishing Co. Inc., New York, 1973, pp. 253–262.Google Scholar
  13. 13.
    KAMPINE. J.P., BRADY, R.O., KANFER, J.N., FELD, M. & SHAPIRO, D.–Diagnosis of Gaucher“s disease and Niemann-Pick disease with small samples of venous blood. Science, 155: 86–88, 1967.CrossRefGoogle Scholar
  14. 14.
    KOLODNY, E.H. & MUMFORD, R.A.–Human leukocyte acid hydro-lases: Characterization of eleven lysosomal enzymes and study of reaction conditions for their automated analysis. Clin.Chim.Acta, 70: 247–257, 1976.PubMedCrossRefGoogle Scholar
  15. 15.
    LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R. J.–Protein measurement with the Folin phenol reagent. J.Biol.Chem., 193: 265–275, 1951.PubMedGoogle Scholar
  16. 16.
    MARTENSON, E., ÖHMAN. R., GRAVES, M. & SVENNERHOLM, L.–Galactosyltransferases catalyzing the formation of the galactosyl-galactosyl linkage in glycosphingolipids. J.Biol. Chem., 249: 4132–4137, 1974.Google Scholar
  17. 17.
    ÖCKERMAN, P.A. & KöHLIN, P.–Tissue acid hydrolase activities in Gaucher-s disease. Scand.J.Lab.Invest, 22: 62–64, 1968.CrossRefGoogle Scholar
  18. 18.
    SVENNERHOLM, L.–Molecular Neuropathology. In Perspectives in Brain Research, M.A.Corner & D.F.Swaab (eds.), Progr.Brain Research, vol. 45, Elsevier, Amsterdam, 1976, pp. 101–121.Google Scholar
  19. 19.
    SVENNERHOLM, L., HAKANSSON, G. & VANIER, M.T.–Chemical pathology of Krabbe-s disease. IV. Studies of galactosyl ceramide and lactosylceramide ß-galactosidases in brain, white blood cells and amniotic fluid cells. Acta Paediat.Scand., 64: 649–656, 1975.PubMedCrossRefGoogle Scholar
  20. 20.
    TANAKA, H. & SUZUKI, K.–Substrate specificities of the two genetically distinct human brain ß-galactosidases. Brain Res., 122: 325–335, 1977.PubMedCrossRefGoogle Scholar
  21. 21.
    TANAKA, H. & SUZUKI, K.–Lactosylceramidase assays for diagnosis of globoid cell leukodystrophy and GM1-gangliosidosis. Clin.Chim.Acta, 75: 267–274, 1977.PubMedCrossRefGoogle Scholar
  22. 22.
    VANIER, M.T. & SVENNERHOLM, L.–Chemical pathology of Krabbe disease: The occurrence of psychosine and other neutral sphingoglycolipids. In Current Trends in Sphingolipidoses and Allied Disorders, B.W.Volk & L.Schneck (eds.), Plenum Press, New York, 1976, pp. 115–126.CrossRefGoogle Scholar
  23. 23.
    WENGER, D.A., SATTLER, M., CLARK, C. & MCKELVEY, H.–An improved method for the identification of patients and carriers of Krabbe“s disease. Clin.Chim.Acta, 56: 199–206, 1974.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • Lars Svennerholm
    • 1
  1. 1.Department of Neurochemistry, Psychiatric Research CentreUniversity of Göteborg, S:t Jörgen HospitalHisings Backa 3Sweden

Personalised recommendations